Abstract:Objective: To ascertain the COVID-19 vaccination acceptance and the factors contributing to vaccine hesitancy and vaccine confidence in the adult population, and the intention for vaccination of their children.Methods: This cross-sectional analysis reports the ancillary results of a population-based SARS-CoV-2 serosurvey conducted in Delhi, India, from September 24 to October 14, 2021. Data were collected from 20312 adult participants through a multistage sampling method from all the 274 wards in the 11 distri… Show more
“…Factors positively influencing the acceptance of COVID-19 vaccination are extensive public knowledge about COVID-19, where 70% of the population that had better knowledge about the vaccines [ 35 ], and a good attitude towards it. The likelihood that a participant might acknowledge vaccine acceptance increased with their perception of their risk of suffering from COVID-19, their belief that the vaccine would protect them from COVID-19, and their belief that the vaccine would not cause any negative adverse consequences.…”
Section: Resultsmentioning
confidence: 99%
“…In the study by Sharma P et al, among the population residing in Delhi, most of them were hesitant about the acceptance of the COVID-19 vaccine. The main causes were a lack of knowledge about COVID-19 immunisations and concerns about vaccine efficacy and long-term efficacy [ 35 ]. In their survey, Kusuma Y. et al discovered that the elderly generation has a lower psychological vulnerability to acquiring COVID-19, a lower perceived threat of COVID-19, poor self-defense against COVID-19, and a lack of awareness and non-use of the Aarogya SetuApp as major determinants of vaccine reluctance [ 36 ].…”
Section: Discussionmentioning
confidence: 99%
“… Acceptance of the COVID-19 vaccine in India according to residence, as shown in the form of a forest plot [ 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 ]. …”
This systematic review and meta-analysis sought to evaluate the acceptability levels for COVID vaccine(s) in various states in India. Published articles in PubMed/Scopus/Cochrane/DOAJ/the Web of Science that focused on assessing COVID-19 vaccine hesitation/vaccine acceptance using a survey/questionnaire were included. After extensive research, 524 records were found, and after screening on the basis of eligibility criteria, only 23 papers were added to this review. Increased vaccine assumption percentage (>70%) among the population was found in two surveys nationwide (92.8%) and in Delhi (79.5%). For pooled estimates of COVID-19 vaccine acceptance and heterogeneity, twenty-three studies (23) consisting of 39,567 individuals reported for acceptance of COVID 19 vaccine in India.. Out of these, 26,028 individuals accepted the COVID-19 vaccine, giving a pooled estimate of 62.6% (95% CI: 55.6–69.4) with considerable heterogeneity (χ2 = 3397.3, p < 0.0001; I2 = 99.40%). The results of this study give a brief insight into the percentage acceptance and hesitancy among the Indian population regarding COVID-19 vaccine immunisation. Future research and vaccine education initiatives can be steered by the findings of this work as a starting point.
“…Factors positively influencing the acceptance of COVID-19 vaccination are extensive public knowledge about COVID-19, where 70% of the population that had better knowledge about the vaccines [ 35 ], and a good attitude towards it. The likelihood that a participant might acknowledge vaccine acceptance increased with their perception of their risk of suffering from COVID-19, their belief that the vaccine would protect them from COVID-19, and their belief that the vaccine would not cause any negative adverse consequences.…”
Section: Resultsmentioning
confidence: 99%
“…In the study by Sharma P et al, among the population residing in Delhi, most of them were hesitant about the acceptance of the COVID-19 vaccine. The main causes were a lack of knowledge about COVID-19 immunisations and concerns about vaccine efficacy and long-term efficacy [ 35 ]. In their survey, Kusuma Y. et al discovered that the elderly generation has a lower psychological vulnerability to acquiring COVID-19, a lower perceived threat of COVID-19, poor self-defense against COVID-19, and a lack of awareness and non-use of the Aarogya SetuApp as major determinants of vaccine reluctance [ 36 ].…”
Section: Discussionmentioning
confidence: 99%
“… Acceptance of the COVID-19 vaccine in India according to residence, as shown in the form of a forest plot [ 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 ]. …”
This systematic review and meta-analysis sought to evaluate the acceptability levels for COVID vaccine(s) in various states in India. Published articles in PubMed/Scopus/Cochrane/DOAJ/the Web of Science that focused on assessing COVID-19 vaccine hesitation/vaccine acceptance using a survey/questionnaire were included. After extensive research, 524 records were found, and after screening on the basis of eligibility criteria, only 23 papers were added to this review. Increased vaccine assumption percentage (>70%) among the population was found in two surveys nationwide (92.8%) and in Delhi (79.5%). For pooled estimates of COVID-19 vaccine acceptance and heterogeneity, twenty-three studies (23) consisting of 39,567 individuals reported for acceptance of COVID 19 vaccine in India.. Out of these, 26,028 individuals accepted the COVID-19 vaccine, giving a pooled estimate of 62.6% (95% CI: 55.6–69.4) with considerable heterogeneity (χ2 = 3397.3, p < 0.0001; I2 = 99.40%). The results of this study give a brief insight into the percentage acceptance and hesitancy among the Indian population regarding COVID-19 vaccine immunisation. Future research and vaccine education initiatives can be steered by the findings of this work as a starting point.
“…Failure to vaccinate nearly 85-90% of the vulnerable adult population was a major factor driving the second wave of the COVID-19 pandemic in India for it is well-established that vaccination with most of the available COVID-19 vaccines significantly reduces the odds of severe disease, hospitalization, and death [2][3][4]. Vaccine hesitancy referring to the delay in the acceptance or refusal of vaccines despite their availability was a significant reason for the low uptake of COVID-19 vaccines in India prior to the Delta wave especially among eligible health workers, comorbid, and older people [5,6].…”
BackgroundOver 2,40,000 deaths were attributed to the SARS-CoV-2 Delta (B.1.617.2) variant in India during the second wave of the pandemic from April to June 2021 with most deaths occurring in the unvaccinated population. High levels of coronavirus disease 2019 (COVID-19) vaccine hesitancy contributed to significantly reduced vaccination coverage in the eligible population especially among healthcare workers, comorbid and older people. The existing global evidence suggests misinformation through social media to accentuate, while newspaper and mainstream media reporting to be protective against vaccine hesitancy during the COVID-19 pandemic. Content analysis of regular press coverage of COVID-19 vaccination in India during the period of initial deployment and until the onset of the second wave of the pandemic can provide useful learnings and strengthen preparedness for addressing potential vaccine hesitancy concerns during future pandemics. Therefore, we conducted this inductive content analysis of press coverage related to the COVID-19 vaccine hesitancy in India prior to the second (Delta) wave of the COVID-19 pandemic.
“…The researchers, who conducted the surveys in 2020–21, found that vaccine acceptance may vary over time according to what information the general public is exposed to at a particular moment. 13 , 14 Many studies have investigated COVID-19 vaccine acceptance in individual countries, but to our knowledge no study has compared vaccine acceptance among the general population of countries based on their HDI score. Therefore, this study aimed to compare beliefs about and barriers to COVID-19 vaccine acceptance in countries with varied HDI scores.…”
Background
As vaccination is a cornerstone strategy to prevent the spread of COVID-19, this study assessed and compared beliefs about and barriers to COVID-19 vaccination among the population of three countries with different Human Development Index (HDI) scores: Saudi Arabia (very high), India (medium), and Sudan (low).
Methods
A web-based, self-administered structured questionnaire was employed to collect data from the three countries. The questionnaire contained three sections that measured sociodemographic characteristics, participants’ beliefs about and attitudes toward COVID-19 vaccines, barriers to receiving COVID-19 vaccines, and scenarios in which there is a possibility to take a COVID-19 vaccine. Multinomial logistic regression was used to determine whether there was an association between the country of the participant and their beliefs about COVID-19 vaccines.
Results
972 responses were collected. The study participants from India were more likely to believe in the safety and efficacy of vaccines than those from Saudi Arabia or Sudan. Consequently, they reported more willingness to get vaccinated to avoid complications from COVID-19. Regarding barriers to COVID-19 vaccination, concerns about adverse effects and ineffectiveness of vaccines were more common among Saudi participants, while concerns about conspiracy were more common among Sudanese participants.
Conclusion
COVID-19 vaccine acceptance was higher in countries with a very high to medium Human Development Index, indicating greater belief in the safety and efficacy of COVID-19 vaccines.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.